Business Context and Reporting Period
Company: AbbVie Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 20, 2020
Event: Extension of expiration dates for Exchange Offers and Consent Solicitations related to the proposed acquisition of Allergan plc.
Key Financial Metrics
This filing is a current report regarding a corporate transaction event and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Expiration Date Extension: AbbVie extended the expiration date for its Exchange Offers and Consent Solicitations from 5:00 p.m. New York City time on April 24, 2020, to 5:00 p.m. New York City time on May 1, 2020.
- Future Extensions: The Expiration Date is expected to be further extended to occur on or about the closing date of the Allergan Acquisition.
- Transaction Scope: The offers involve exchanging outstanding notes issued by Allergan entities (Allergan Notes) for new notes issued by AbbVie (AbbVie Notes) and adopting amendments to eliminate covenants and guarantees in the Allergan Notes indentures.
Guidance, Outlook, and Risks
- Conditions Precedent: The Exchange Offers and Consent Solicitations are conditioned upon the consummation of the Allergan Acquisition, a condition that cannot be waived by AbbVie.
- Settlement Timing: Settlement is expected to occur promptly after the Expiration Date.
- Regulatory Status: The AbbVie Notes offered have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. absent registration or an applicable exemption.
- Operative Status: Supplemental indentures effecting the amendments were executed on November 7, 2019, but will only become operative upon settlement of the Exchange Offers.
Investor Verification Checklist
- Verify the status of the proposed acquisition of Allergan plc, as the exchange offers are contingent upon its consummation.
- Monitor for further press releases regarding additional extensions of the Expiration Date beyond May 1, 2020.
- Review the confidential offering memorandum and consent solicitation statement (dated October 25, 2019, as amended) for detailed terms of the AbbVie Notes.
- Confirm the settlement date once the Expiration Date passes.